Association of PALB2 sequence variants with the risk of familial and early-onset breast cancer in a South-American population.

ABSTRACT: Germline mutations in PALB2 have been identified in approximately 1% of familial breast cancer (BC) in several populations. Nevertheless its contribution in the South-American population is unknown. The goal of this study was to determine the prevalence of PALB2 mutations in the Chilean population.100 Chilean BRCA1/2-negatives familial BC cases were included for the PALB2 mutation analysis. We use conformational sensitive gel electrophoresis and direct sequencing. Using a case-control design, we studied the identified variants in 436 BC cases and 809 controls to evaluate their possible association with BC risk.No pathogenic mutations were detected. We identified three variants, the variant c.1861C?>?A not previously described was found in one of the 436 cases and none of the 809 controls. The bioinformatic analyses indicate that this variant probably is not pathogenic. PALB2 c.1676A?>?G (rs152451A/G) and c.2993C?>?T (rs45551636C/T) variants were significantly associated with increased BC risk only in cases with a strong family history of BC (OR?=?1.9 [CI 95% 1.3-2.8] p??G and c.2993C?>?T play roles in BC risk in women with a strong family history of BC.

SUBMITTER: Leyton Y 

PROVIDER: S-EPMC4323211 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature